$LABT

$0.24 -$0.05 (16.74%) Close

$LABT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 2.4M shares outstanding

Who owns LABT?

By type of holder

Institutions 4.1% Insiders 0.0% Everyone else 95.9%

Concentration Top 6 holders own 4.1%

Marex Group Ltd 2.0% · HRT Financial LP 1.9%

Institutional ownership

4.1%

+4.1 pts vs last qtr

Institutional holders

+6 vs last qtr

Net shares bought

+97.8K

by institutions in Q2 2026

New / sold out

6 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Marex Group Ltd NEW +48.2K
HRT Financial LP NEW +44.8K

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Lakewood-Amedex Biotherapeutics Inc in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Lakewood-Amedex Biotherapeutics Inc.

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%

Quarterly turnover

—

of institutional shares changed hands

Top 10 managers, median time held

0 quarters

Super Investors

Investment managers reporting LABT on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
MG Marex Group Ltd	48.2K	2.03%	NEW	Q2 '26	0.0%
Shares held by quarter Peak holding48.2K (Q2'26) Change over 8 quarters+48.2K Share of the company2.030% Marex Group Ltd's full portfolio →
HF HRT Financial LP	44.8K	1.89%	NEW	Q2 '26	0.0%
Shares held by quarter Peak holding44.8K (Q2'26) Change over 8 quarters+44.8K Share of the company1.890% HRT Financial LP's full portfolio →

Marex Group Ltd

48.2K

% of company

2.03%

Change vs last qtr

NEW

Held since

Q2 '26

HRT Financial LP

44.8K

% of company

1.89%

Change vs last qtr

NEW

Held since

Q2 '26

4 more super investors behind a free account

See every manager holding Lakewood-Amedex Biotherapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting LABT on Form N-PORT; together they hold 1.9% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FN Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust	$108K	43.3K	1.83%	0.00%	August 31, 2026
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$3.73K	1.5K	0.06%	0.00%	August 31, 2026

Fidelity Nasdaq Composite Index Fund

Fidelity Concord Street Trust

Position value

$108K

% of company

1.83%

% of the fund

0.00%

As of

August 31, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$3.73K

% of company

0.06%

% of the fund

0.00%

As of

August 31, 2026

Comments